Clemens von Birgelen, MD, PhD

Impact of Gender on Femoral Access Complications Secondary to Application of a Collagen-based Vascular Closure Device

08/01/2008

Holger Eggebrecht , MD;

Knut Kröger , MD;

Axel Schmermund , MD;

Heinrich Wieneke , MD;

Thomas Bartel , MD;

Uta Wörtgen , MD;

Dietrich Baumgart , MD;

Clemens von Birgelen , MD, PhD;

Michael Haude , MD;

Raimund Erbel , MD;

Christoph K. Naber , MD;

ABSTRACT: Background: Vascular complications at the femoral access site continue to be a significant problem after cardiac catheterization procedures. It was the aim of the present study to assess the impact of gender on the incidence of...

ABSTRACT: Background: Vascular...

08/01/2008

Journal of Invasive Cardiology

Calcium Corner

TWENTE: Abbott’s Xience V Stent and Medtronic’s Resolute Go Head-to-Head

12/05/2011

Clemens von Birgelen , MD, PhD;

What is the history of comparisons between the Xience V and Resolute stents?The TWENTE trial is actually the second, prospective, randomized trial between Resolute and Xience V in patients with complex coronary artery disease. The first, the...

What is the history of...

12/05/2011

Cath Lab Digest